1. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

   • James K. Liao

   Clinical Trials Report 14 June 2009 Pages: 243 - 244

2. Genetically elevated C-reactive protein and ischemic vascular disease

   • James K. Liao

   Clinical Trials Report 14 June 2009 Pages: 245 - 245

3. Moving toward new statin guidelines in a post-JUPITER world: Principles to consider

   • Paul M. Ridker

   OriginalPaper 14 June 2009 Pages: 249 - 256

4. Diet and lifestyle influences on risk of coronary heart disease

   • Frank B. Hu

   OriginalPaper 14 June 2009 Pages: 257 - 263

5. Metabolic syndrome: Perception or reality?

   • David C. W. Lau

   OriginalPaper 14 June 2009 Pages: 264 - 271

6. Planning primary prevention of coronary disease

   • Bill Lands

   OriginalPaper 14 June 2009 Pages: 272 - 280

7. Efficacy of peroxisome proliferator-activated receptor agonists in diabetes and coronary artery disease

   • Catherine Fiévet
   • Bart Staels

   OriginalPaper 14 June 2009 Pages: 281 - 288

8. Circadian rhythm and cardiovascular disease

   • Elizabeth Shaw
   • Geoffrey H. Tofler

   OriginalPaper 14 June 2009 Pages: 289 - 295

9. Statins and ischemic stroke severity: Cytoprotection

   • Larry B. Goldstein

   OriginalPaper 14 June 2009 Pages: 296 - 300

10. Chronic kidney disease and statins: Improving cardiovascular outcomes

    • D. Benson Walker
    • Thanh Jennifer Walker
    • Terry A. Jacobson

    OriginalPaper 14 June 2009 Pages: 301 - 308

11. Statins and their use in preventing carotid disease

    • Henrik Sillesen

    OriginalPaper 14 June 2009 Pages: 309 - 314

12. Review of the SPARCL trial and its subanalyses

    • Kenneth M. Welch

    ReviewPaper 14 June 2009 Pages: 315 - 321